ApHER conducted analyses in a project recently presented at ISPOR 2019, New Orleans

2019-06-20T11:25:27+00:00 June 20th, 2019|Categories: Diseases of the nervous system, Health Economics, Nordic Health Registers, Pharmacoepidemiology|

Anastasija Komkova and Thomas Fast from ApHER conducted analyses in a research project examining the healthcare resource utilization and medication burden in epilepsy patients before and after initiating the antiepileptic drug perampanel. The project was presented in a poster at ISPOR 2019 in New Orleans, LA, on May 18-22. Further information and link for the poster [...]

Nordic Evidence Leaders Forum – Stockholm May 14-15 2019

2019-05-20T13:26:08+00:00 May 20th, 2019|Categories: Health Economics, Nordic Health Registers, Pharmacoepidemiology, Uncategorised|

Thomas was a speaker at the Nextlevel Life Sciences Conference in Stockholm in May 2019. During the conference, Thomas shared ApHER´s experience of pooling Nordic data

Thomas Fast at the 8th National Health Economic Conference

2019-03-18T15:09:40+00:00 March 18th, 2019|Categories: Health Economics, Nordic Health Registers|

This Wednesday Thomas Fast attended the 8th National Health Economic Conference in Örebro where he presented some of the work we are doing in ApHER in regards to pooling Nordic data. The conference was held on March 12-13 and it was arranged by the Swedish Health Economic Association (SHEA) in cooporation with Region Örebro county and [...]

New publication: Electronic Health Lifestyle Coaching Among Diabetes Patients in a Real-Life Municipality Setting: Observational Study

2019-03-18T12:44:24+00:00 March 18th, 2019|Categories: Endocrine, nutritional and metabolic diseases, Health Economics|

Our paper "Electronic Health Lifestyle Coaching Among Diabetes Patients in a Real-Life Municipality Setting: Observational Study" was recently published in The Journal of Medical Internet Research. The study assessed the effects associated with the electronic health (eHealth) intervention among obese diabetes patients in a real-life municipal setting. A real-life eHealth lifestyle coaching intervention was implemented in [...]

Meet Thomas Fast from ApHER at the Nordic Evidence Leaders Forum in Stockholm

2019-03-18T11:03:08+00:00 March 18th, 2019|Categories: Health Economics, Nordic Health Registers, Pharmacoepidemiology|

Demonstrating the safety profile of a new drug intervention is a pre-requisite for market access. Thomas will introduce the structure of Nordic health register data with a case on how a multi-country safety study was developed to support market access by including health economic aspects in the study design. The Nordic region is regarded as one [...]

ApHER at ISPOR Barcelona 2018: Cost of multiple sclerosis

2018-11-16T13:57:43+00:00 November 16th, 2018|Categories: Diseases of the nervous system, Health Economics, Nordic Health Registers|

ApHER participated at ISPOR Europe 2018 and presented a study “COSTS OF MULTIPLE SCLEROSIS IN DENMARK: A REGISTER BASED STUDY”. The unique registers in Denmark allow us to include in the study all individuals with Multiple Sclerosis (MS) in Denmark.  All Individuals with MS in 2014 were ascertained and characterized by treatment from the Danish health [...]

Danish Cancer Research Days 30-31 August 2018

2018-11-16T13:58:46+00:00 September 28th, 2018|Categories: Cancer, Health Economics|

ApHER participated at the cancer research days presenting the CEDAR study, a nationwide, observational study including all patients living with cancer of the lung, breast, bladder, ovary, and prostate as of 31st December 2005 and all patients first-time diagnosed from then up to 31st December 2015. Patients are followed from date of first diagnosis until death [...]

New study: Many patients go for years without seeing a sclerosis doctor

2018-09-28T14:14:20+00:00 April 6th, 2018|Categories: Diseases of the nervous system, Health Economics, Nordic Health Registers, Pharmacoepidemiology|

Six out of ten of the sclerosis patients who are not in disease-modifying treatment do not attend annual follow-ups. This means that the patients do not receive the symptom management or rehabilitation they need. These results come from a new study by ApHER conducted in collaboration with the Danish Multiple Sclerosis Society, presented by Prof. Anders Green [...]

It is a good investment to prevent the development of lifestyle diseases such as diabetes

2018-09-28T13:44:19+00:00 March 31st, 2018|Categories: Endocrine, nutritional and metabolic diseases, Health Economics, Nordic Health Registers|

A poorly regulated diabetes patient is costly for both the public healthcare system and the private insurance companies. In a recent cost-effectiveness study of the LIVA platform ApHER concludes that there is a desirable investment return by managing diabetes patients digitally through online lifestyle coaching. Read the article at LIVA Healthcare here.

UTURN – a life without pills

2018-08-20T15:11:44+00:00 January 14th, 2017|Categories: Endocrine, nutritional and metabolic diseases, Health Economics|

The program UTURN - a life without pills on DR1 (Danish national television), is a part of a research project at Rigshospitalet in Copenhagen, which examines wheter an intensive life style intervention in diabetes patients can reduce patients' need for pharmaceutical treatment for diabetes. Camilla Sorts from ApEHR explains in this program the socio-economical cost of [...]